Intracellular Sensing of DNA in Autoinflammation and Autoimmunity

Area of Science:

• Immunology
• Genetics
• Molecular Biology

Background:

• DNA is recognized as a pathogen-associated molecular pattern, creating challenges in distinguishing self from non-self DNA.
• Autoinflammatory diseases, often monogenic, involve periodic inflammation driven by endogenous DNA accumulation or aberrant DNA-sensing pathways.
• Murine models demonstrate that endogenous DNA and DNA sensing can drive disease pathogenesis.

Purpose of the Study:

• To review the current understanding of intracellular DNA sensing and signaling in autoinflammatory diseases.
• To explore the role of endogenous DNA in human autoimmune diseases.
• To identify therapeutic targets within DNA-sensing pathways.

Main Methods:

• Literature review of autoinflammatory and autoimmune diseases linked to DNA sensing.
• Analysis of genetic mutations affecting DNA homeostasis and sensing pathways.
• Examination of evidence from murine models and human disease studies.

Main Results:

• Mutations in DNA-regulating genes or DNA-sensing components cause autoinflammatory conditions.
• Endogenous DNA is implicated in the pathogenesis of systemic rheumatic diseases, including lupus erythematosus.
• Specific monogenic disorders like Stimulator of interferon genes-associated vasculopathy and Aicardi-Goutières syndrome are associated with DNA-sensing pathway dysregulation.

Conclusions:

• Intracellular DNA sensing pathways are critical in both autoinflammatory and autoimmune diseases.
• Targeting these DNA-sensing pathways offers potential therapeutic strategies for inflammatory and rheumatic conditions.
• Further research into endogenous DNA's role can illuminate disease mechanisms and guide treatment development.